Lixte Biotechnology Prices $16.6M Registered Direct Offering; Shares Slip After Deal Announcement
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) disclosed a $16.6 million registered direct offering that led to a 3.4% decline in its stock price. The deal includes the sale of 2,625,362 shares of common stock and immediately exercisable pre-funded warrants priced at $0.0001, at an offering price of $6.31 per share. The transaction, priced at the m…